CARLSBAD, Calif; ZURICH; VIENNA--(BUSINESS WIRE)--With partnering deals still driving drug development markets, this year’s BIO-Europe conference is set to establish new standards for generating quality partnering meetings and providing the insights needed to successfully operate in an era of dramatic biotech industry change. Many of the most respected industry thought leaders and decision makers will once again travel to BIO-Europe to examine the issues, new business approaches and policy trends that are vital to biotech’s successful long term future. To date, there are already 2,002 licensing opportunities, an impressive 1,170 companies from 46 countries registered, and over 2,000 delegates actively booking one-to-one meetings.
